Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Rheumatoid Arthritis Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

109 recruiting trials for Rheumatoid Arthritis. Eligibility criteria explained in plain English.

TrialFinderData lists 109 Rheumatoid Arthritis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 1 is the largest group at 40% (17 studies); the largest phase groups are Phase 1: 17, Phase 2: 11, Phase 3: 4, Phase 4: 3.

Research is led by The Danish Center for Expertise in Rheumatology (3), Assistance Publique - Hôpitaux de Paris (3), Shanghai Changzheng Hospital (2), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (other, 10 trials), followed by Methotrexate, Fludarabine.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
109
Total Trials
109
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Track Rheumatoid Arthritis trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06426316

The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.

Migraine is a frequent and debilitating neurologic disorder. It is more frequent in women, and more prevalent in patients with autoimmune and/or inflammatory diseases such as...

Sponsor: University Hospital, Clermont-FerrandEnrolling: 3961 location
RECRUITINGPhase 4NCT07160231

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

The goal of this clinical trial is to assess the effectiveness of a disease activity guided dose reduction strategy of Janus kinase inhibitor (JAKi) compared to disease activity...

Sponsor: Sint MaartenskliniekEnrolling: 2007 locations
RECRUITINGNCT07052565

CAR-T Cells Therapy for Patients With Autoimmune Diseases

This is an open label, single-site, dose-escalation study in up to 18 participants with refractory autoimmune diseases. This study aims to evaluate the safety and efficacy of the...

Sponsor: Anhui Provincial HospitalEnrolling: 181 location
RECRUITINGNCT05603728

Exactech Shoulder Post Market Clinical Follow-up Study

The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder...

Sponsor: ExactechEnrolling: 2000020 locations
RECRUITINGPhase 1NCT07171983

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

Sponsor: Bristol-Myers SquibbEnrolling: 469 locations
RECRUITINGNCT06947746

HiSCs in the Treatment of Rheumatoid Arthritis

This trial is a single-center, single-arm exploratory clinical study aimed at assessing the safety, tolerability, and preliminary efficacy of a single intra-articular injection of...

Sponsor: Shanghai Changzheng HospitalEnrolling: 151 location
RECRUITINGPhase 2NCT07118241

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML...

rhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in subjects with Sjögren's related...

Sponsor: Lubris Bio Pty LtdEnrolling: 806 locations
RECRUITINGNCT04931160

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made by expert doctors...

Sponsor: University Hospital, BrestEnrolling: 10001 location
RECRUITINGPhase 2NCT06599658

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

The goal of this pragmatic embedded open-label, 2 x 2 factorial phase II randomized controlled trial is to evaluate strategies to improve COVID-19 booster and influenza vaccine...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 6603 locations
RECRUITINGNCT05302934

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

Prospective, multinational pilot study for evaluation of the Pheno4U data platform in Total Knee Arthroplasty (TKA) patients

Sponsor: Aesculap AGEnrolling: 6004 locations
RECRUITINGPhase 1NCT05638854

A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid...

This double-blind, randomized, placebo-controlled study will assess the safety and pharmacokinetics of ZB002 in healthy participants and in participants with rheumatoid arthritis...

Sponsor: Zenas BioPharma (USA), LLCEnrolling: 722 locations
RECRUITINGNCT06536075

Functional Analysis of Salivary Glands and Correlation With Sialoscintigraphy in Sjogren's Syndrome

Sjögren's syndrome is a complex autoimmune disorder. The investigators hypothesize that striated ductal cells may function as non-professional antigen-presenting cells in...

Sponsor: National Taiwan University HospitalEnrolling: 601 location
RECRUITINGNCT06696027

AYLo - AutoimmunitY and Loss of y

The AYLo study (AutoimmunitY and Loss of y - Investigating the Role of Hematopoietic Mutations and Mosaic Mutation in the Y Chromosome in Autoimmune Rheumatologic Diseases) aims...

Sponsor: University of BonnEnrolling: 5001 location
RECRUITINGNCT06812481

Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory rheumatological disease. Use of corticosteroids for more than 3 months in RA treatment is considered...

Sponsor: Balikesir UniversityEnrolling: 1001 location
RECRUITINGPhase 1NCT05003934

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Rheumatoid...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 202 locations
RECRUITINGNCT04731831

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

The aim of the study is to explore whether the influence of gender, tobacco smoking and obesity on treatment response in tumor necrosis factor inhibitors (TNFIs) can be explained...

Sponsor: Aalborg University HospitalEnrolling: 1201 location
RECRUITINGPhase 1NCT06647069

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

This is an open-label, multi-ascending dose (MAD) phase 1 study, with dose expansion at selected doses, in adult patients with select autoimmune rheumatic diseases including...

Sponsor: SanofiEnrolling: 627 locations
RECRUITINGNCT07138729

Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis

This study proposes to evaluate 99mTc-CTR-FAPI SPECT imaging as a cost-effective, low-radiation, and widely accessible alternative to 68Ga-FAPI PET/CT for assessing synovial...

Sponsor: Luo YapingEnrolling: 201 location
RECRUITINGNCT06933134

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Evaluation of the prediction of clinical response to rituximab at a dose of 1000 mg once using a pharmacological model including several pharmacokinetic and pharmacodynamic...

Sponsor: University Hospital, ToursEnrolling: 301 location
RECRUITINGNCT05790356

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 301 location
RECRUITINGNCT06503237

Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis

This is an open label, single-site, dose-escalation study in up to 18 participants with refractory rheumatoid arthritis. This study aims to evaluate the safety and efficacy of the...

Sponsor: The First Affiliated Hospital of University of Science and Technology of ChinaEnrolling: 181 location
RECRUITINGNCT07222696

Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being

The goal of this clinical trial is to learn if peer coaching works to reduce levels of anxiety and/or depression in adults diagnosed with Rheumatoid Arthritis (RA). The main...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 2501 location
RECRUITINGNCT05003310

ConsideRAte Study - Splenic Stimulation for RA

This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable...

Sponsor: Galvani BioelectronicsEnrolling: 2814 locations
RECRUITINGPhase 2NCT06794008

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

The objective of this study is to evaluate the efficacy and safety of BCMA/CD19 chimeric antigen receptor (CAR)-modified T cells in the treatment of autoimmune diseases.

Sponsor: Peking University People's HospitalEnrolling: 501 location
RECRUITINGNCT07484243

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine...

This is a large-scale, multicenter observational study on the treatment of rheumatoid arthritis (RA) with integrated Traditional Chinese and Western medicine. The study plans to...

Sponsor: Yuanyuan ZhangEnrolling: 100001 location
RECRUITINGEarly Phase 1NCT06548607

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of CD19 or...

Sponsor: Nanjing Bioheng Biotech Co., Ltd.Enrolling: 201 location
RECRUITINGPhase 2NCT06780293

Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi...

Sponsor: Taipei Veterans General Hospital, TaiwanEnrolling: 1401 location
RECRUITINGPhase 3NCT07404865

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Sponsor: Vor BiopharmaEnrolling: 25020 locations
RECRUITINGNCT06397677

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators...

Sponsor: University of Colorado, DenverEnrolling: 4504 locations
RECRUITINGPhase 1NCT05197530

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

Lymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established...

Sponsor: University of RochesterEnrolling: 401 location
RECRUITINGNCT05391100

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease

The quantitative and qualitative analysis of RA lung involvement in the Hungarian population

Sponsor: Polyclinic of the Hospitaller Brothers of St. John of God, BudapestEnrolling: 5003 locations
RECRUITINGPhase 1NCT06902519

Study of GS-0151 in Participants With Rheumatoid Arthritis

The goal of this clinical study is to learn more about the study drug GS-0151. The study is done to find how safe, well-tolerated the drug is. This will also assess how the drug...

Sponsor: Gilead SciencesEnrolling: 7520 locations
RECRUITINGNCT07660029

BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote...

The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid...

Sponsor: University of UlsterEnrolling: 201 location
RECRUITINGNCT05278520

Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis

The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.

Sponsor: University of TurkuEnrolling: 1104 locations
RECRUITINGPhase 4NCT05626348

The Clinical Efficacy of Immunomodulators in RA Patients

This study includes naive patients and csDMARDs-IR RA patients, treated with different regimens such as Iguratimod combination of different csDMARDs, or csDMARD with TNF...

Sponsor: Qilu Hospital of Shandong UniversityEnrolling: 4001 location
RECRUITINGNCT06299917

WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis

People with chronic inflammatory arthritis (IA) (rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis), often have a reduced work ability. Up to 40% lose their...

Sponsor: The Danish Center for Expertise in RheumatologyEnrolling: 561 location
RECRUITINGNCT07000916

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or...

Sponsor: Université Catholique de LouvainEnrolling: 10001 location
RECRUITINGPhase 1 / Phase 2NCT07062523

Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT

Sjögren's syndrome (SS) is a chronic autoimmune disease primarily affecting the salivary and lacrimal glands, leading to symptoms of dryness. Assessing the inflammatory activity...

Sponsor: Peking Union Medical College HospitalEnrolling: 601 location
RECRUITINGNCT02469662

Clinical Outcomes Study of the Nexel Total Elbow

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

Sponsor: Zimmer BiometEnrolling: 13411 locations
RECRUITINGNCT07442773

Intervention to Support Partners and Informal Caregivers of Frail RA-patients

Background Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with pain, fatigue, functional limitations, and reduced quality of life. As more people live to...

Sponsor: Glostrup University Hospital, CopenhagenEnrolling: 251 location
RECRUITINGNCT04848870

Dental and Periodontal Status of Patients With Sjögren's Syndrome.

Sjögren's syndrome (SS) is a rare chronic systemic autoimmune disease characterized by destruction of the exocrine glands, including the salivary glands.The lack of saliva exposes...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1001 location
RECRUITINGNCT06574594

Effect of MTX Discontinuation on Shingrix Response in RA

The goal of this clinical trial is to learn if methotrexate discontinuation affect on immunogeneity of shingrix in RA patients. The main questions it aims to answer are:...

Sponsor: Konkuk University Medical CenterEnrolling: 1101 location
RECRUITINGPhase 1NCT07201558

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA...

Sponsor: AstraZenecaEnrolling: 4819 locations
RECRUITINGPhase 3NCT06456489

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Remission or low disease activity in active rheumatoid arthritis

Sponsor: Sohag UniversityEnrolling: 2681 location
RECRUITINGNCT07469540

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid...

The goal of this clinical trial is to determine whether an aerobic exercise program can reduce cardiovascular risk in patients with systemic inflammation, such as those with...

Sponsor: Jérôme BouchanEnrolling: 901 location
RECRUITINGEarly Phase 1NCT07526350

MTS109 in Patients With Refractory Autoimmune Diseases

This is the first-in-human trial of MTS109 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS109 in moderate to...

Sponsor: Shanghai Changzheng HospitalEnrolling: 151 location
RECRUITINGPhase 2NCT07409103

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients...

This is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants...

Sponsor: Elevara Medicines LimitedEnrolling: 18020 locations
RECRUITINGPhase 1NCT07363590

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 2117 locations
RECRUITINGNCT07381296

Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis

The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data,...

Sponsor: Sohag UniversityEnrolling: 2001 location
RECRUITINGNCT07264101

Validity And Reliability Of The Four Square Step Test In Individuals With Rheumatoid Arthritis

This cross-sectional observational study aims to evaluate the validity and reliability of the Four Square Step Test (FSST) in individuals with rheumatoid arthritis. In addition,...

Sponsor: Inonu UniversityEnrolling: 501 location

Showing 50 of 109 trials.Search all Rheumatoid Arthritis trials

Frequently Asked Questions

There are currently 109 clinical trials for Rheumatoid Arthritis, with 109 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Rheumatoid Arthritis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 4 Phase 3 trials for Rheumatoid Arthritis, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.